Solid Tumors Cell Therapies, Vaccines
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT06636682
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 14, 2024
Completion: May 4, 2027
Loading map...